13 Nov 2023 Research
This year’s Olive Boles Innovation Award winner announced
Dr Kevin Rattigan, University of Glasgow, has been selected as this year’s Olive Boles Innovation Award winner – an accolade given to one Leukaemia UK John Goldman Fellow each year. The award recognises an innovative, higher risk idea that could contribute significantly to our understanding of leukaemia.
Dr Rattigan’s pioneering research sets out to test a potential new treatment for acute myeloid leukaemia (AML) – a type of leukaemia with a devastatingly low survival rate in the UK of around 13.6% after five years.
Dr Rattigan has already revealed a checklist of nutrients that AML needs to survive and has now developed a protein that can lower levels of one of these key nutrients. As part of his fellowship, Dr Rattigan will now test if his developed protein could be a potential new treatment option to slow or stop leukaemia and if so, whether it could be combined with existing AML treatments to make them more effective.
This research focuses specifically on AML, but if successful, could also have benefits for other blood cancers and beyond in the future.
Dr Rattigan said ‘I am honoured to be awarded both the Leukaemia UK John Goldman Fellowship and Olive Boles Innovation Award. This funding from Leukaemia UK means so much to me as it supports me in developing new treatments for AML patients. I am very grateful that my work is to be recognised by an award named after the inspirational Olive Boles who created the John Goldman fellowship. Thank you to all the charity’s donors whose generosity makes this research possible.’
19 September 2023
“Fundraising never tasted so good!”: Star-studded evening raises over £235,000 for life-saving leukaemia research
Chefs and celebrities mingled at The Dorchester last night for a gastronomic spectacular in aid of Leukaemia UK, raising over £235,000 to support world-class research into the devastating disease. Who’s…
17 October 2023
Leukaemia UK announces four pioneering projects into one of the deadliest forms of cancer
Applications for the 2024 John Goldman Fellowships will open on 01 December 2023. The deadline for applications is 12 noon on 31 January 2024. Find out more and apply. Leukaemia UK…
19 June 2023
Leukaemia UK research paves the way for personalised lymphoma treatment
Despite promising trials, standard treatment for diffuse large B-cell lymphoma (DLBCL) hasn’t changed in a decade. New treatment strategies for this type of blood cancer are urgently needed. Could the…
10 January 2023
Clinical trial begins for pioneering new cancer treatment
Dr Konstantinos Tzelepis was awarded a Leukaemia UK research fellowship in 2020 and has developed a new class of cancer drug with the potential to treat leukaemia.